Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
NCT05781152Phase 4Active, not recruiting
- Sponsor
- Connecticut Children's Medical Center
- Start
- Jun 2023
- Primary completion
- Jul 2028
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial in Crohn's disease, sponsored by Connecticut Children's Medical Center. Primary endpoint: Complete healing (CH) at 52 weeks. Started Jun 2023; status: active, not recruiting.
02
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT05781152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05781152.